Telecommunications Press Releases
SEE OTHER BRANDS

The latest telecommunications news from the world

Telecommunications Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecommunications Press Releases.

Press releases published on May 12, 2025

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context …

Pixalate’s April 2025 US Publisher Rankings: Top Mobile ‘Sports’ Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

Pixalate’s April 2025 US Publisher Rankings: Top Mobile ‘Sports’ Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

London, May 12, 2025 (GLOBE NEWSWIRE) -- Pixalate, a leading global platform for ad fraud protection, privacy, and compliance analytics, today released the U.S. April 2025 Top Mobile ‘Sports’ Apps Rankings for Programmatic Advertising Traffic Quality on …

Pixalate’s April 2025 US Publisher Rankings: Top Mobile Gaming Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

Pixalate’s April 2025 US Publisher Rankings: Top Mobile Gaming Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

London, May 12, 2025 (GLOBE NEWSWIRE) -- Pixalate, the market-leading ad fraud protection, privacy, and compliance analytics platform, today released the U.S. April 2025 Top Mobile Gaming Apps Rankings for Programmatic Advertising Traffic Quality on the …

ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress

ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress

KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for Cholesterol Efflux MediatorTM VAR 200 in patients with diabetic kidney disease (DKD). Obesity-associated cardiometabolic preclinical …

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update

Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapy SEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for its total tumor regression data in …

KBRA Affirms Ratings for Heritage Commerce Corp

KBRA Affirms Ratings for Heritage Commerce Corp

SAN JOSE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Heritage Commerce Corp (NASDAQ: HTBK) (the "Company"), parent company of Heritage Bank of Commerce (the "Bank"), announced today that Kroll Bond Rating Agency, LLC ("KBRA") affirmed the Company’s senior …

Worksport Announces First Quarter 2025 Earnings Release Date and Conference Call Details

Worksport Announces First Quarter 2025 Earnings Release Date and Conference Call Details

West Seneca, New York, May 12, 2025 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator and manufacturer of hybrid and clean energy solutions primarily for the light truck, overlanding, and global …

Carbon Revolution Sets Date for Fiscal 2024 Earnings Release and Conference Call

Carbon Revolution Sets Date for Fiscal 2024 Earnings Release and Conference Call

GEELONG, Australia, May 12, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 automotive supplier and the world’s leading manufacturer of innovative, lightweight carbon fiber wheels, announced today it will hold a …

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive topline results from Phase 1 study of TNX- …

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and …

Satellogic Secures Multi-Million Dollar Agreement with Asia Pacific Customer

Satellogic Secures Multi-Million Dollar Agreement with Asia Pacific Customer

DAVIDSON, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in high-resolution Earth observation data, announced today it has entered into a multi-million dollar agreement with an Asia Pacific customer. The agreement provides …

Vireo Growth Inc. Announces Closing of WholesomeCo Cannabis & Arches Merger Transactions

Vireo Growth Inc. Announces Closing of WholesomeCo Cannabis & Arches Merger Transactions

– Acquisitions strengthen profitability and competitive position with proprietary technology platform – – Missouri and Nevada transactions remain on track to close during the second quarter of 2025 – MINNEAPOLIS, May 12, 2025 (GLOBE NEWSWIRE) -- Vireo …

Cellectis Reports Financial Results for the First Quarter 2025

Cellectis Reports Financial Results for the First Quarter 2025

Lasme-cel (UCART22) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025 Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late 2025 …

Fuel Tech Reports 2025 First Quarter Financial Results

Fuel Tech Reports 2025 First Quarter Financial Results

Select First Quarter 2025 Highlights Revenue rose 29% to $6.4 million Gross margin expanded to 46.4% Operating loss narrowed to $1.0 million Backlog rose 66% to $10.3 million Cash, cash equivalents and investments of $31.2 million, no long-term debt …

Jones Soda Sets First Quarter 2025 Conference Call for Thursday, May 15, 2025, at 4:30 p.m. ET

Jones Soda Sets First Quarter 2025 Conference Call for Thursday, May 15, 2025, at 4:30 p.m. ET

SEATTLE, May 12, 2025 (GLOBE NEWSWIRE) -- Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), today announced it will hold a conference call on Thursday, May 15, 2025, at 4:30 p.m. Eastern time to discuss its financial and operational …

Editas Medicine Announces First Quarter 2025 Results and Business Updates

Editas Medicine Announces First Quarter 2025 Results and Business Updates

Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 promoter editing cargo to hematopoietic stem and progenitor cells (HSPCs) at ASGCT this week Company will also share in vivo …

Pixalate’s April 2025 United Kingdom Publisher Rankings: Top Mobile Gaming Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

Pixalate’s April 2025 United Kingdom Publisher Rankings: Top Mobile Gaming Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

London, May 12, 2025 (GLOBE NEWSWIRE) -- Pixalate, the market-leading ad fraud protection, privacy, and compliance analytics platform, today released the United Kingdom's April 2025 Top Mobile Gaming Apps Rankings for Programmatic Advertising Traffic …

Life360 Reports Record Q1 2025 Results

Life360 Reports Record Q1 2025 Results

Monthly Active Users Reached Approximately 83.7 million Record Q1 Global Net Additions to Paying Circles of 137 thousand - Reaching 2.4 million Total Total Quarterly Revenue Grew 32% Year-Over-Year to $103.6 million Annualized Monthly Revenue increased 38% …

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

FDA Breakthrough Device Designation Awarded to AVIM Therapy FDA IDE Approved for Virtue SAB U.S. Pivotal Trial for Launch NEW HOPE, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a …

ODDITY Announces Block Trade of Class A Ordinary Shares

ODDITY Announces Block Trade of Class A Ordinary Shares

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (the “Company”) (NASDAQ: ODD) today announced the sale of 5,500,000 shares of its Class A ordinary shares by an entity affiliated with Oran Holtzman, ODDITY co-founder and CEO. The transaction …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service